Smoking, oral contraceptives, and cardiovascular reactivity to stress

Obstetrics and Gynecology

Volumn 95, Issue 1, 2000, Pages 78-83

  Straneva, Patricia ^a   Hinderliter, Alan ^b   Wells, Ellen ^b   Lenahan, Heather ^a   Girdler, Susan ^a,b  

^a UNIVERSITY OF NORTH CAROLINA   (United States)

^b UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN; ORAL CONTRACEPTIVE AGENT;

ADULT; ARTICLE; CARDIOVASCULAR RESPONSE; CONTRACEPTION; DOSE RESPONSE; FEMALE; HEART INDEX; HEART RATE; HEMODYNAMICS; HUMAN; HUMAN EXPERIMENT; NORMAL HUMAN; PRIORITY JOURNAL; SMOKING; STRESS; SYSTOLIC BLOOD PRESSURE; VASCULAR RESISTANCE;

ADULT; BLOOD PRESSURE; CARDIOVASCULAR SYSTEM; CONTRACEPTIVES, ORAL; FEMALE; HUMANS; SMOKING; STRESS, PSYCHOLOGICAL; VASCULAR RESISTANCE;

EID: 0033988465     PISSN: 00297844     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0029-7844(99)00497-4     Document Type: Article

References (29)

1. Ellis J. Low-dose oral contraceptives Progestin potency, androgenicity and artherogenic potential . Clin Ther. 8:1986;607-618.
2. Farhat M.Y., Wolfe R., Vargas R., Foegh M.L., Ramwell P.W. Effect of testosterone treatment on vasoconstrictor response of left anterior descending coronary artery in male and female pigs. J Cardiovascular Pharmacology. 25:1995;495-500.
3. Levy D., Garrison R.J., Savage D.D., Kannel W.B., Castelli W.P. Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study. N Engl J Med. 222:1990;1561-1566.
4. Davis M.C., Matthews K.A. Cigarette smoking and oral contraceptive use influence women's lipid, lipoprotein, and cardiovascular responses during stress. Health Psychol. 9:1990;717-736.
5. Emmons K.M., Weidner G. The effects of cognitive and physical stress on cardiovascular reactivity among smokers and oral contraceptive users. Psychophysiology. 25:1988;166-171.
6. Manuck S.B., Kasprowicz A.L., Muldoon M.F. Behaviorally-evoked cardiovascular reactivity and hypertension Conceptual issues and potential associations . Ann Behav Med. 12:1990;17-29.
7. Girdler S.S., Jamner L.D., Jarvik M., Soles J.R., Shapiro D. Smoking status and nicotine administration differentially modify hemodynamic stress reactivity in men and women. Psychom Med. 59:1997;294-306.
8. Spielberger C., Gorusch R., Lushene R. STAI manual for the state-trait anxiety inventory. 1970;Consulting Psychologists Press, Palo Alto, California.
9. Sherwood A., Allen M.T., Fahrenberg J., Kelsey R.M., Lovallo W.R., van Doornen L.J. Methodological guidelines for impedance cardiography. Psychophysiology. 27:1990;1-23.
10. Kubicek W.G., Karnegis J.N., Patterson R.P., Witsoe D.A., Mattson R.H. Development and evaluation of an impedance cardiac output system. Aerospace Med. 37:1966;1208-1212.
11. Friedewald W.T., Levy R.I., Fredrickson D.S. Estimation of the concentration of LDL-c in plasma without the use of preparative ultracentrifuge. Clin Chem. 18:1972;513-517.
12. Beck A., Ward C., Mendelson M., Mock J., Erbauch J. An inventory for measuring depression. Arc Gen Psychiatry. 4:1961;561-571.
13. Pearlin L., Menaghan E., Lieberman M., Mullan J. The stress process. J Health Soc Behav. 22:1981;337-356.
14. Rosenberg M. Society and the adolescent self-image. 1965;Princeton University Press, Princeton, New Jersey.
15. Chesney M.A., Rosenman R.H. Anger and hostility in cardiovascular and behavioral disorders. 1985;Hemisphere Publishing Corp, Washington, DC.
16. Cohen S., Mermelstein R., Kamark T., Hoberman H. Measuring the functional components of social support. Sarason I.G., Sarason B.R. Social support Theory, research and applications . 1985;73-94 Kluwer Publishing, Boston.
17. Cohen S., Kamark T., Mermelstein R. A global measure of perceived stress. J Health Soc Behav. 24:1993;385-396.
18. Cook W., Medley D. Proposed hostility and pharasaic-virtue scales for the MMPI. J Appl Psychol. 38:1954;414-418.
19. Saab P.G., Llabre M.M., Schneiderman N., Hurwitz B., McDonald P.G., Evans J., et al. Influence of ethnicity and gender on cardiovascular responses to active coping and inhibitory-passive coping challenges. Psychosomatic Med. 59:1997;434-446.
20. Green M.S., Jucha E., Luz Y. Blood pressure in smokers and nonsmokers Epidemiologic findings . Am Heart J. 111:1986;932-940.
21. Lasutiola K.E., Lassila R., Kaprio J., Koskenvuo M. Decreased beta-adrenergic receptor density and catecholamine response in male cigarette smokers. A study of monozygotic twin pairs discordant for smoking. Circulation. 78:1988;1234-1240.
22. MacMahon B., Trichopoulos D., Cole P., Brown J. Cigarette smoking and urinary estrogens. N Engl J Med. 307:1982;1062-1065.
23. Michnovicz J.J., Hershcopf R.J., Naganuma H., Bradlow H.L., Fishman J. Increased 2-hydroxylation of estradiol as a possible mechanism for the anti-estrogenic effect of cigarette smoking. N Engl J Med. 315:1986;1305-1309.
24. Cassidenti D.L., Vijod A.G., Vijod M.A., Stanczyk F.Z., Lobo R.A. Short-term effects of smoking on the pharmacokinetic profiles of micronized estradiol in postmenopausasl women. Am J Obstet Gynecol. 163:1990;1953-1960.
25. Pines A., Fisman E.Z., Levo Y., Averbuch M., Lidor A., Drory Y., et al. The effects of hormone replacement therapy in normal postmenopausal women Measurements of Doppler-derived parameters of aortic flow . Am J Obstet Gynecol. 164:1991;806-812.
26. Treiber F.A., McCaffrey F., Pflieger K., Raunikar R.A., Strong W.B., Davis H. Determinants of left ventricular mass in normotensive children. Am J Hypertens. 6:1993;505-513.
27. Godsland I.F., Crook D., Devenport M., Wynn V. Relationships between blood pressure, oral contraceptive use, and metabolic risk markers for cardiovascular disease. Contraception. 52:1995;143-149.
28. Jick H., Jick S.S., Gurewich V., Wald Myers M., Vasilakis C. Risk of idiopathic cardiovascular death and nonfatal venous thromboembolism in women using oral contraceptives with differing progestagen components. Lancet. 346:1995;1589-1593.
29. Martinelli I., Sacchi E., Landi G., Taioli E., Duca F., Mannucci P.M. High risk of cerebral-vein thrombosis in carriers of a prothrombin-gene mutation and in users of oral contraceptives. N Engl J Med. 338:1998;1793-1797.